118th Congress · SENATE BILLBILL

S. 113 — Prescription Pricing for the People Act of 2023

“A bill to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.”

Commerce

Introduced Jan 26, 2023

Last action Mar 1, 2023

Pipeline · Bill → Law

Step 1

Introduced

Jan 26, 2023

Step 2

Referred

Jan 26, 2023

the Judiciary

Step 3

Committee

Feb 9, 2023

Reported out

Step 4

Senate

Mar 1, 2023

Step 5

House floor

Step 6

Resolve Changes

Step 7

Signed

SummaryCRS Summary

Prescription Pricing for the People Act of 2023This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.

Provisions · 4 sectionsReported to Senate

Timeline · 5 actions

Mar 1, 2023

Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.

Mar 1, 2023

Placed on Senate Legislative Calendar under General Orders. Calendar No. 19.

Feb 9, 2023

Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.

Jan 26, 2023

Introduced in Senate

Jan 26, 2023

Read twice and referred to the Committee on the Judiciary.